9,133
Total Claims
$652K
Drug Cost
1,040
Beneficiaries
$627
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-59%
Cost per patient vs peers
$627 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,368 claims · $244K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 135 | $140K |
| Rivaroxaban | 97 | $113K |
| Candesartan Cilexetil | 181 | $32K |
| Levothyroxine Sodium | 209 | $26K |
| Dapagliflozin Propanediol | 23 | $25K |
| Empagliflozin | 17 | $23K |
| Metoprolol Succinate | 739 | $22K |
| Losartan Potassium | 758 | $17K |
| Irbesartan | 330 | $13K |
| Rosuvastatin Calcium | 585 | $13K |
| Atorvastatin Calcium | 642 | $10K |
| Candesartan/Hydrochlorothiazid | 36 | $8,421 |
| Enalapril Maleate | 164 | $5,455 |
| Amlodipine Besylate | 695 | $5,341 |
| Losartan/Hydrochlorothiazide | 184 | $5,210 |
Prescribing Profile
80
Unique Drugs
$301K
Patient Profile
75
Avg Age
64%
Female
1.50
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data